🇺🇸 FDA
Company

Vir

Vir Biotechnology

VIR biotech USA

Quick answer

Vir is a biotech company (VIR) headquartered in SAN FRANCISCO, CA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

LY3819253

Covid19

Phase 3 · mab · completed

1 trials project

Tobevibart

Viral Hepatitis

Phase 3 · small_molecule · active

3 trials project

VIR-7831

COVID-19

Phase 3 · mab · completed

1 trials project

VIR-7831 (sotrovimab)

Covid19

Phase 3 · mab · completed

1 trials project

sotrovimab

Covid19

Phase 3 · mab · terminated

3 trials project

BRII-179

For Treatment of Chronic Hepatitis B Virus Infection

Phase 2 · mab · active

1 trials project

BRII-835 (VIR-2218)

Hepatitis B, Chronic

Phase 2 · small_molecule · completed

1 trials project

Bamlanivimab

COVID-19

Phase 2 · small_molecule · completed

1 trials project

PEG-IFNα

Chronic Hepatitis B Virus Infection

Phase 2 · mab · active

1 trials project

Sotrovimab

COVID-19

Phase 2 · mab · terminated

1 trials project

Sotrovimab (Gen1)

Covid19

Phase 2 · mab · completed

1 trials project

Tenofovir Alafenamide

Chronic Hepatitis B

Phase 2 · small_molecule · completed

1 trials project

VIR-2218

Hepatitis B, Chronic

Phase 2 · small_molecule · completed

1 trials project

VIR-2218

Hepatitis D, Chronic

Phase 2 · small_molecule · active

1 trials project

VIR-2482 (450 mg)

Influenza A

Phase 2 · mab · terminated

1 trials project

VIR-3434

Hepatitis B, Chronic

Phase 2 · small_molecule · completed

1 trials project

VIR-5818

Locally Advanced or Metastatic HER2-Expressing Cancers

Phase 2 · small_molecule · active

1 trials project

Sotrovimab

COVID-19 Infection

Phase 1 · mab · terminated

1 trials project

VIR-1111

HIV I Infection

Phase 1 · mab · completed

1 trials project

VIR-2218

Hepatic Impairment

Phase 1 · small_molecule · active

1 trials project

VIR-2218

Renal Impairment

Phase 1 · small_molecule · completed

1 trials project

VIR-2482

Influenza A

Phase 1 · small_molecule · completed

1 trials project

VIR-3434

Chronic Hepatitis B

Phase 1 · mab · completed

1 trials project

VIR-5500

Hormone-refractory Prostate Cancer

Phase 1 · small_molecule · active

1 trials

Patents (6)

patent

US 12404318

Combination HBV therapy

Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11628215

HIV vaccines comprising one or more population episensus antigens

Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11554168

HIV vaccines comprising one or more population episensus antigens

Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11479599

Antibodies against SARS-CoV-2 and methods of using the same

Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11168128

Antibodies against SARS-CoV-2 and methods of using the same

Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10894078

HIV vaccines comprising one or more population episensus antigens

Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)